This inventor holds 9 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC, Millennium Pharmaceuticals Limited. Active years: 2010-2017.
Location History:
- Bolton, MA (US) (2010)
- San Francisco, CA (US) (2011 - 2017)
Company Filing History:
4 out of 386 
3 out of 262 
2 out of 854 
Years Active: 2010-2017
Title: The Innovative Contributions of Jane F. Schmidt
Introduction
Jane F. Schmidt is a prominent inventor based in Bolton, MA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of neprilysin inhibitors. With a total of 9 patents to her name, her work has had a substantial impact on drug development and therapeutic applications.
Latest Patents
Among her latest patents, Jane has focused on compounds that exhibit neprilysin inhibition activity. These compounds are characterized by specific formulas, where R, R, R, X, R, R, and R are defined in the specification. The inventions also encompass pharmaceutical compositions that include these compounds, methods for their use, and processes for their preparation. This innovative work is crucial for advancing treatments in various medical conditions.
Career Highlights
Throughout her career, Jane has worked with notable companies such as Theravance, Inc. and Theravance Biopharma R&D IP, LLC. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical research and development. Jane's contributions have been instrumental in pushing the boundaries of what is possible in drug formulation and therapeutic efficacy.
Collaborations
Jane has collaborated with esteemed colleagues, including Adam D. Hughes and Daisuke Roland Saito. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of her work.
Conclusion
Jane F. Schmidt's innovative contributions to the field of pharmaceuticals, particularly through her work on neprilysin inhibitors, highlight her role as a leading inventor. Her extensive patent portfolio and collaborations with industry professionals underscore her commitment to advancing medical science.